This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimizu, S. Articles by Mitsudomi, T. Search for Related Content PubMed PubMed Citation Articles by Shimizu, S. Articles by Mitsudomi, T.

High Frequency of Clonally Related Tumors in Cases of Multiple Synchronous Lung Cancers as Revealed by Molecular Diagnosis¹

Departments of Thoracic Surgery [S. S., S. H., M. Sh., M. Su., T. M.], Pathology and Clinical Laboratories [Y. Y., T. K.], and Internal Medicine [M. O.], Aichi Cancer Center Hospital, Nagoya 464-8681; Department of Epidemiology [N. H.] and Division of Molecular Oncology [N. H., T. T.], Aichi Cancer Center Research Institute, Aichi Cancer Center, Nagoya 464-8681; Department of Internal Medicine II, Nagoya City University Medical School, Nagoya 467-8601 [S. S., R. U.], Japan

In patients with multiple synchronous lung tumors, discrimination of multicentric lung cancers from intrapulmonary metastasis is important for treatment decision, but this is sometimes difficult. The aim of this study was to retrospectively distinguish multicentric lung cancers from intrapulmonary metastases in 14 such cases by loss of heterozygosity (LOH) and p53 mutational status. DNA was extracted from microdissected tumor cells in paraffin- embedded archival tissue, and 3p14.2, 3p21, 3p25, 9p21, and 18q21.1 were investigated for LOH. Exons 5–8 of the p53 gene were examined for mutations by the PCR, followed by single-strand conformation polymorphism analysis and DNA sequencing. For cases with the same LOH pattern, we calculated a clonality index, the probability of the given LOH pattern when these tumors were hypothesized to be independent in origin. Eleven of 14 cases (79%) were thus diagnosed as having pulmonary metastasis and only one case as having genuinely multicentric lung cancers. Two cases presented difficulty in diagnosis. In several cases, the LOH patterns conflicted with p53 mutation patterns, suggesting that clonal evolution is directly affected by certain genetic changes. The combination of p53 with LOH helped increase both the sensitivity and specificity of the assay.

This article has been cited by other articles:

				X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al. Evidence for Common Clonal Origin of Multifocal Lung Cancers J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570. [Abstract] [Full Text] [PDF]

				A. F. Gazdar and J. D. Minna Multifocal Lung Cancers--Clonality vs Field Cancerization and Does It Matter? J Natl Cancer Inst, April 15, 2009; 101(8): 541 - 543. [Full Text] [PDF]

				A. Oliaro, P. L. Filosso, A. Cavallo, R. Giobbe, C. Mossetti, P. Lyberis, R. C. Cristofori, and E. Ruffini The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 438 - 443. [Abstract] [Full Text] [PDF]

				Y.-L. Chang, C.-T. Wu, and Y.-C. Lee Surgical treatment of synchronous multiple primary lung cancers: Experience of 92 patients J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 630 - 637. [Abstract] [Full Text] [PDF]

				J. L. Port, R. J. Korst, P. C. Lee, A. L. Kansler, Y. Kerem, and N. K. Altorki Surgical Resection for Multifocal (T4) Non-Small Cell Lung Cancer: Is the T4 Designation Valid? Ann. Thorac. Surg., February 1, 2007; 83(2): 397 - 400. [Abstract] [Full Text] [PDF]

				Y.-L. Chang, C.-T. Wu, S.-C. Lin, C.-F. Hsiao, Y.-S. Jou, and Y.-C. Lee Clonality and Prognostic Implications of p53 and Epidermal Growth Factor Receptor Somatic Aberrations in Multiple Primary Lung Cancers Clin. Cancer Res., January 1, 2007; 13(1): 52 - 58. [Abstract] [Full Text] [PDF]

				B. L. Schlechter, Q. Yang, P. S. Larson, A. Golubeva, R. A. Blanchard, A. de Las Morenas, and C. L. Rosenberg Quantitative DNA Fingerprinting May Distinguish New Primary Breast Cancer From Disease Recurrence J. Clin. Oncol., May 15, 2004; 22(10): 1830 - 1838. [Abstract] [Full Text] [PDF]

				T. Koga, Y. Horio, T. Mitsudomi, T. Takahashi, and Y. Yatabe Identification of MGB1 as a Marker in the Differential Diagnosis of Lung Tumors in Patients with a History of Breast Cancer by Analysis of Publicly Available SAGE Data J. Mol. Diagn., May 1, 2004; 6(2): 90 - 95. [Abstract] [Full Text] [PDF]

				J. R.M. van der Sijp, J. P.A.M. van Meerbeeck, A. P.W.M. Maat, P. E. Zondervan, H. F.B.M. Sleddens, A. N. van Geel, A. M.M. Eggermont, and W. N.M. Dinjens Determination of the Molecular Relationship Between Multiple Tumors Within One Patient Is of Clinical Importance J. Clin. Oncol., February 15, 2002; 20(4): 1105 - 1114. [Abstract] [Full Text] [PDF]